T. Rowe Price Associates’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $114K | Sell |
|
|||||
|
2025
Q3 | $215K | Sell |
|
|||||
|
2025
Q2 | $790K | Sell |
|
|||||
|
2025
Q1 | $1.52M | Buy |
|
|||||
|
2024
Q4 | $644K | Buy |
|
|||||
|
2024
Q3 | $945K | Sell |
|
|||||
|
2024
Q2 | $6.81M | Sell |
|
|||||
|
2024
Q1 | $10.2M | Sell |
|
|||||
|
2023
Q4 | $127M | Buy |
|
|||||
|
2023
Q3 | $123M | Buy |
|
|||||
|
2023
Q2 | $67.5M | Buy |
|
|||||
|
2023
Q1 | $54.7M | Buy |
|
|||||
|
2022
Q4 | $11.5M | Sell |
|
|||||
|
2022
Q3 | $20.4M | Sell |
|
|||||
|
2022
Q2 | $70.4M | Sell |
|
|||||
|
2022
Q1 | $86.5M | Sell |
|
|||||
|
2021
Q4 | $111M | Sell |
|
|||||
|
2021
Q3 | $121M | Buy |
|
|||||
|
2021
Q2 | $178M | Buy |
|